Management of Hematologic Disorders
Summary
- Therapy is not always necessary because 1% to 20% of patients may experience spontaneous remission, and the incidence of significant bleeding is low despite low platelet counts[Walsh 1985; Brusamolino 1989]
- In absence of HIV infection, rituximab associated with complete remission in 98% of relapsed/refractory ITP cases and longer median PFS vs conventional therapy[Tun 2012]; limited data on rituximab use for HIV-associated ITP Antiretroviral Therapy
- Standard of care for patients with HIV-associated thrombocytopenia is ART initiation
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Hematologic Complications